1. Home
  2. PSO vs BIO Comparison

PSO vs BIO Comparison

Compare PSO & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pearson Plc

PSO

Pearson Plc

N/A

Current Price

$13.00

Market Cap

8.9B

ML Signal

N/A

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$313.31

Market Cap

8.7B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PSO
BIO
Founded
1844
1952
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Books
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.9B
8.7B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
PSO
BIO
Price
$13.00
$313.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
N/A
$358.50
AVG Volume (30 Days)
766.9K
189.5K
Earning Date
02-27-2026
02-12-2026
Dividend Yield
2.56%
N/A
EPS Growth
31.65
N/A
EPS
0.90
N/A
Revenue
$4,822,578,436.00
$2,557,500,000.00
Revenue This Year
$2.36
$1.62
Revenue Next Year
$5.20
$2.26
P/E Ratio
$13.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.42
$211.43
52 Week High
$17.90
$373.69

Technical Indicators

Market Signals
Indicator
PSO
BIO
Relative Strength Index (RSI) 39.09 47.26
Support Level $12.42 $306.52
Resistance Level $14.84 $316.63
Average True Range (ATR) 0.25 9.16
MACD -0.17 -0.67
Stochastic Oscillator 22.52 40.16

Price Performance

Historical Comparison
PSO
BIO

About PSO Pearson Plc

UK-listed Pearson is a testing and educational provider. Pearson's primary operations are in assessment and qualification testing and higher education, but they also provide English education and testing, virtual learning, prehiring testing and screening, and upskilling/reskilling. The company divested noncore businesses, including the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: